What Are Celgene's Key Sources of Revenue?

Celgene (NASDAQ:CELG) is a global biopharmaceuticals company, which has recently entered into a merger agreement with Bristol-Myers Squibb in a deal valued at $74 billion. Celgene generates its revenues primarily from sales of drugs used for the treatment of cancer and inflammatory diseases world...